domingo, 25 de mayo de 2014

Sequential Gastroenteritis Episodes Caused by 2 Norovirus Genotypes - Volume 20, Number 6—June 2014 - Emerging Infectious Disease journal - CDC

full-text ►



Sequential Gastroenteritis Episodes Caused by 2 Norovirus Genotypes - Volume 20, Number 6—June 2014 - Emerging Infectious Disease journal - CDC







link to Volume 20, Number 6—June 2014



Volume 20, Number 6—June 2014

Dispatch

Sequential Gastroenteritis Episodes Caused by 2 Norovirus Genotypes

Gabriel I. ParraComments to Author  and Kim Y. GreenComments to Author 
Author affiliations: National Institutes of Health, Bethesda, Maryland, USA

Abstract

We investigated sequential episodes of acute norovirus gastroenteritis in a young child within an 11-month period. The infections were caused by 2 distinct genotypes (GII.4 and GII.6). Failure to achieve cross-protective immunity was linked to absence of an enduring and cross-reactive mucosal immune response, a critical consideration for vaccine design.
Noroviruses are major pathogens associated with acute gastroenteritis in persons of all ages. It is estimated that each year in developing countries, noroviruses are responsible for up to 200,000 deaths of children <5 years of age (1). Moreover, in the United States, because of the successful implementation of vaccination against rotaviruses, noroviruses have emerged as the leading cause of severe gastroenteritis requiring medical intervention among infants and young children (2).
Noroviruses are genetically diverse, and differences in the major capsid protein (VP1) have led to their classification into 6 genogroups (GI–GVI) and ≈30 genotypes. Noroviruses from genogroups GI, GII, and GIV infect humans; worldwide, GII.4 is the most prevalent genotype (35). Expression of VP1 results in self-assembly of virus-like particles that have been used to examine structural and antigenic differences among genotypes (3,68). However, lack of an in vitro cell culture system has hindered the ability to establish serotype differences by neutralization. Initial evidence for the existence of at least 2 distinct norovirus serotypes came from early studies among volunteers; these studies showed that infection with Norwalk or Hawaii viruses (representing GI and GII, respectively) did not induce cross-protection (9). Evidence also exists for the periodic emergence of new GII.4 strain variants that cause large global epidemics, possibly driven by escape from herd immunity (5,10). Further understanding of the natural history of these viruses is needed to establish the potential role of genotypic and antigenic variation in vaccine development.

Dr Green is chief of the Caliciviruses Section of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. Her research is directed toward the prevention and control of acute gastrointestinal disease caused by noroviruses.

Acknowledgments



We thank Rachel J. Dexter and Ronald W. Jones for their technical assistance and Stanislav V. Sosnovtsev for helpful discussions.
This research was funded by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health.
Dr Parra is a visiting fellow at the National Institute of Allergy and Infectious Diseases, National Institutes of Health. His research interests include epidemiology, immunology, and vaccine development against gastrointestinal viral infections.

References

  1. Patel MMWiddowson MAGlass RIAkazawa KVinje JParashar UDSystematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis.2008;14:122431 . DOIExternal Web Site IconPubMedExternal Web Site Icon
  2. Payne DCVinje JSzilagyi PGEdwards KMStaat MAWeinberg GANorovirus and medically attended gastroenteritis in U.S. children. N Engl J Med2013;368:112130DOIExternal Web Site IconPubMedExternal Web Site Icon
  3. Kroneman AVega EVennema HVinje JWhite PAHansman GProposal for a unified norovirus nomenclature and genotyping. Arch Virol2013;158:205968DOIExternal Web Site IconPubMedExternal Web Site Icon
  4. Glass RIParashar UDEstes MKNorovirus gastroenteritis. N Engl J Med.2009;361:177685 . DOIExternal Web Site IconPubMedExternal Web Site Icon
  5. Siebenga JJVennema HZheng DPVinje JLee BEPang XLNorovirus illness is a global problem: emergence and spread of norovirus GII.4 variants, 2001–2007. J Infect Dis.2009;200:80212DOIExternal Web Site IconPubMedExternal Web Site Icon
  6. Jiang XWang MGraham DYEstes MKExpression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol1992;66:652732 .PubMedExternal Web Site Icon
  7. Parra GIAbente EJSandoval-Jaime CSosnovtsev SVBok KGreen KYMultiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo–blood group antigens. J Virol2012;86:741426DOIExternal Web Site IconPubMedExternal Web Site Icon
  8. Hansman GSNatori KShirato-Horikoshi HOgawa SOka TKatayama KGenetic and antigenic diversity among noroviruses. J Gen Virol2006;87:90919 . DOIExternal Web Site IconPubMedExternal Web Site Icon
  9. Wyatt RGDolin RBlacklow NRDuPont HLBuscho RFThornhill TSComparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers.J Infect Dis1974;129:70914DOIExternal Web Site IconPubMedExternal Web Site Icon
  10. Lindesmith LCDonaldson EFLobue ADCannon JLZheng DPVinje JMechanisms of GII.4 norovirus persistence in human populations. PLoS Med2008;5:e31DOIExternal Web Site IconPubMedExternal Web Site Icon
  11. van Beek JAmbert-Balay KBotteldoorn NEden JSFonager JHewitt JIndications for worldwide increased norovirus activity associated with emergence of a new variant of genotype II.4, late 2012. Euro Surveill2013;18:89 .PubMedExternal Web Site Icon
  12. Debbink KLindesmith LCDonaldson EFBaric RSNorovirus immunity and the great escape. PLoS Pathog2012;8:e1002921DOIExternal Web Site IconPubMedExternal Web Site Icon
  13. Parrino TASchreiber DSTrier JSKapikian AZBlacklow NRClinical immunity in acute gastroenteritis caused by Norwalk agent. N Engl J Med1977;297:869DOIExternal Web Site IconPubMedExternal Web Site Icon
  14. Lindesmith LMoe CMarionneau SRuvoen NJiang XLindblad LHuman susceptibility and resistance to Norwalk virus infection. Nat Med2003;9:54853DOIExternal Web Site IconPubMedExternal Web Site Icon
  15. Saito MGoel-Apaza SEspetia SVelasquez DCabrera LLoli SMultiple norovirus infections in a birth cohort in a Peruvian periurban community. Clin Infect Dis.2014;58:48391 .DOIExternal Web Site IconPubMedExternal Web Site Icon

Figures

Suggested citation for this article: Parra GI, Green KY. Sequential gastroenteritis caused by 2 norovirus genotypes. Emerg Infect Dis [Internet]. 2014 Jun [date cited].http://dx.doi.org/10.3201/eid2006.131627External Web Site Icon
DOI: 10.3201/eid2006.131627
Sequential Gastroenteritis Episodes Caused by 2 Norovirus Genotypes - Volume 20, Number 6—June 2014 - Emerging Infectious Disease journal - CDC

No hay comentarios:

Publicar un comentario